BioNJ’s 14th Annual BioPartnering Conference

Latest Posts

What’s New in Ontosight^® Terminal 1.1

What’s New in Ontosight® Terminal 1.1 A Complete Guide toRead More

3

Jun 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

featured, Press release 2024

Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...

23

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

featured, Press release 2024

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...

Innoplexus wins Horizon Interactive Gold Award for Curia App

BioNJ’s 14th Annual BioPartnering Conference

Join Dr. Gunjan Bhardwaj, Founder & CEO, Dr. Frank Grams, CCO, and Sven Krause, President – North America for Partex at BioNJ’s BioPartnering Conference.

BioNJ’s 14th Annual BioPartnering Conference, the premier partnering event for entrepreneurs looking to connect with investors and biopharmaceutical companies for funding and collaboration opportunities is taking place on the 14th of May in Jersey City, NJ, USA.

Explore Collaboration: Learn how Partex’s innovative approach can accelerate your drug development journey!

Speaker:
Dr. Gunjan Bhardwaj
Founder & CEO Partex

Attendee:
Dr. Frank Grams
CCO, Partex

Sven Krause
President, Partex, North America

Date:
May 14, 2024

Venue:
Jersey City, NJ USA

BioNJ's-BioPartnering-Conference-illustration

To find out more details visit: https://bionj.org/bionj-biopartnering-conference/

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	The cookies are used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is used to store whether or not a user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Latest Posts

What’s New in Ontosight^® Terminal 1.1

3

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

23

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

BioNJ’s 14th Annual BioPartnering Conference

WHO WE ARE

WHAT WE OFFER

HOW WE WORK

WHY US

Updates

Frankfurt (Germany)

Pune (India)

Iselin (USA)

Cham (Switzerland)

Ontosight^® Terminal

FREE for a limited time